Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in HIV/HCV-coinfected drug-naïve patients

por Macías, J, Mallolas, J, López-Cortés, LF, Cartón, JA, Domingo, P, Moreno, S, Iribarren, JA, Neukam, K, Rodrigo, A, Jiménez-Expósito, MJ, Pineda, JA
Publicado 2010

Full blood count values as a predictor of poor outcome of pneumonia among HIV-infected patients

por Camon, S., Quiros, C., Saubi, N., Moreno, A., Marcos, M. A., Eto, Y., Rofael, S., Monclus, E., Brown, J., McHugh, T. D., Mallolas, J., Perello, R.
Publicado 2018

Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapy

por Perello, R., Vergara, A., Monclus, E., Jimenez, S., Montero, M., Saubi, N., Moreno, A., Eto, Y., Inciarte, A., Mallolas, J., Martínez, E., Marcos, M. A.
Publicado 2019

CD4 response, lipid changes and liver outcome in 506 patients receiving nevirapine-based regimens for a median of 9 years

por Podzamczer, D, Tiraboschi, JM, Mallolas, J, Cárdenes, MA, Casas, E, Castro, A, Echevarria, S, Leal, M, Bernanldo de Quirós, JC Lopez, Moreno, S, Puig, T, Ribera, E, Villalonga, C, Gomez Sirvent, JL, Garcia Heranejos, JA, Lopez-Aldeguer, J, Barrufet, P, Force, L, Santos, I, Sanz, J
Publicado 2010